Compound ID | 1911
Synonym(s): SM-1652
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. Binds to bacterial penicillin-binding proteins (PBP); PBP inhibitor |
| Target Pathogen: | Active against Gram-positive bacteria and against many Enterobacteriaceae but vulnerable to extended-spectrum beta-lactamases (ESBL) |
| Description: | Semisynthetic Cephalosporine, derived from Cephalosporin C |
| Institute where first reported: | Wyeth Ayerst |
| Year first mentioned: | 1982 |
| Highest development stage: | Approved by FDA in 1989 |
| Development status: | Approved |
| Reason dropped: | Discontinued/Withdrawn in other countries |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/636405 |
| Guide to Pharmacology: | cefpiramide |
| Citation: | https://www.jiac-j.com/article/S1341-321X(00)71317-1/fulltext |